Showing 678 results
Permanent hearing loss may be reversible
A new mouse study suggests we may be able to reverse permanent hearing loss in humans by tapping into a latent regenerative ability.
The key to fighting fungal infections may have been inside us all along
MIT researchers have discovered that complex molecules in mucus can keep fungal infections in check.
"Complex" and "exciting": Researchers study the use of CBD for pain
In a small study, researchers at Syracuse found that both thinking you’re getting CBD for pain and the drug increase pain tolerance.
Diabetes drug shows promise as obesity treatment
The diabetes drug semaglutide shows promise as an obesity treatment, helping people lose an average of 34 pounds in a recent trial.
Military vet’s lightweight mask is protecting soldiers from toxic fumes
A Canadian military veteran's innovative mask is protecting soldiers, police, and first responders from toxic exposure.
New surgery implants living, 3D-printed body parts
A 3D-printed outer ear made from the patient’s own cells has been implanted.
Scientists call Alzheimer’s amyloid theory into question
What if amyloid plaques are not the cause of Alzheimer’s, but instead a symptom? New research suggests restoring liquid amyloid may be key.
IBM’s artificial intelligence may help us defeat superbugs
A new AI tool detected 20 viable drug candidates in less than two months
Harnessing nature’s secret: How synthetic biology could save the planet
In partnership with Ginkgo Bioworks
Did nature hold the key to reversing climate change all along? Synthetic biologists think so.
Ketamine infusion: What it's like and how it works
Ketamine infusion therapy takes the anesthetic from dance floors to depression clinics. But how does the drug work, and what is it like?
Blood test can quickly tell if a targeted cancer therapy works
The ExoSCOPE blood test can determine with 95% accuracy whether a targeted cancer therapy is working within 24 hours of administration.
Gene therapy shows promise at treating severe form of epilepsy
A new Dravet syndrome treatment that targets genes could help extend the lives of people with the rare, but severe form of epilepsy.
Series|
Catalysts
Applying Silicon Valley thinking to the fight against poverty
In partnership with Stand Together
“Change happens from the bottom up.”
Existing chemo drugs could offer a potential Ebola treatment
Capable of causing highly lethal disease, Ebola treatment is a public health priority. A new study shows chemo drugs may do just that.
Robot fish are powered by lab-grown human heart cells
A robot fish that uses human heart cells to swim has put scientists one step closer to growing full-size hearts in the lab.
Neuralink rival will soon test brain implant in US clinical trials
It's the first time the FDA has approved clinical trials for a brain-computer interface.
Sonic waves could help bones grow back after cancer
A technique that turns stem cells into bone cells using only sound waves could help people regrow bone destroyed by disease.
Tiny robotic crab, controlled by lasers, can run, twist, and jump
A new robotic crab has a sophisticated structure for its size, but it can still be manufactured using a relatively simple process.
Phase 2 trial finds psychedelic works as well as common drug
A small study has provided evidence of psilocybin for depression working as well as a popular SSRI.
Why at-home STI tests may (finally) be about to take off
Inspired by the home testing of the pandemic and rising STI cases, some experts think that more accessible testing may be an important public health tool.
Should psychedelics be patented?
The issue of patents has riven the psychedelic field. A lawyer’s repository of psychedelic info may make sure the new field stays fair.
Low doses of nitrous oxide may treat depression
A new, small study has found that low doses of nitrous oxide — laughing gas — can treat symptoms of depression.
Six benefits that the metaverse offers to colleges and universities
Colleges and universities are keen to jump on the metaverse bandwagon, even before knowing what the metaverse really is.
This engineer fixed his own heart
When Tal Golesworthy was told he was at risk of his aorta bursting, he wasn’t impressed with the surgery on offer – so he came up with his own idea.
Inhaled nanobodies treat COVID-19 in hamsters
An inhaled nanobody treatment for COVID-19 has shown promise in animal tests and could be a more affordable alternative to monoclonal antibody drugs.
Lucky accident shows how immune system can beat MRSA without antibiotics
Researchers have accidentally found that blocking caspase enzymes can make mouse immune responses more robust.
These innovative projects are tackling homelessness around the world
It’s been estimated that at least 150 million people, which is about 2% of the world’s population, are homeless.
Color-changing gold tattoo can monitor your health
Researchers have found a way to use gold nanoparticles to help diagnose medical problems by embedding them in an invisible tattoo.
Space lettuce engineered to stimulate bone growth
To protect Mars astronauts from bone loss, scientists genetically engineered a lettuce that produces a bone-stimulating hormone.
How Daybreaker turned “sober morning raves” into a worldwide movement
In partnership with Million Stories
What started as a side project among friends quickly grew into a multimillion-dollar business.
New cancer treatment uses “hot blood cells” to target tumors
A new cancer treatment combining immunotherapy, photothermal therapy, and modified blood cells was highly effective in mice.
Can CBD be the next superbug slayer?
In the search for new weapons against superbugs, CBD and antibiotics in combination, as well as CBD alone, may prove to be promising candidates.
New Ebola antibodies neutralize the most dangerous strains of the virus
Researchers have found two new antibodies which bind to the most dangerous strains of Ebola.
Fighting poverty with direct cash payments
GiveDirectly has delivered over $500 million in cash to impoverished people, letting recipients decide how best to meet their needs.
Pfizer is testing a coronavirus antiviral
Pfizer is testing a new coronavirus antiviral that has stopped SARs-CoV-2 from replicating in the lab in humans.
Vaccine used to treat COVID-19 for first time
A man whose persistent coronavirus infection kept him isolated for 7 months finally tested negative after receiving a COVID-19 vaccine.
Morning glories may be a source of new psychedelics and medicines
Researchers have found that the symbiotic relationship between a fungus and a morning glory holds the potential for new psychedelic compounds and medicines.
MIT just created a test that can tell if you’re immune to COVID-19
MIT researchers have developed an easy-to-use test that may be able to predict an individual’s immune response to SARS-CoV-2.
Icy microneedle patch delivers cell therapy, then melts
A new microneedle patch features needles made of ice instead of traditional materials, making it suitable for cell therapy delivery.
Saliva: The next frontier in cancer detection
Scientists are finding tumor signals in spit that could be key to developing diagnostic tests for various types of cancer
Scientists use ultrasound to control brain cells in animals
Researchers have used ultrasound to trigger the brain cells of mice with a technique called sonogenetics.
New nano drug may be able to break drug-resistant cancers — with fewer side effects
Drug-resistant cancers reduce the effectiveness of chemo. A team of researchers may have found a potential way to treat them.
Joystick-operated robot could help surgeons treat stroke remotely
With a modified joystick, surgeons in one hospital may control a robotic arm at another location to safely operate on a patient.
These mind-reading helmets could be a Fitbit for your brain
Kernel has developed two mind-reading helmets that record the same brain activity data as massive, million-dollar machines, but cost just $100,000.
A celebrated AI has learned a new trick: How to do chemistry
We had a challenging question for the AI AlphaFold – had its structural training set taught it some chemistry?
How a smartphone app is helping suppress HIV
An HIV app that uses gaming elements to motivate people to stick to their ART regimen was able to increase viral suppression in a small study.
Tweaked psychedelic drug could treat addiction, depression
A modified ibogaine molecule could be a safer and more accessible treatment for addiction and depression than the psychedelic drug in its natural state.
Scientists convert CO2 into synthetic starch
A process for making synthetic starch from CO2 eliminates the need for growing resource-intensive starchy plants.
How long are you too high to drive? The science is fuzzy.
Some drug driving laws outlaw any amount of THC. To create better laws, researchers are trying to find out how long cannabis intoxication itself lasts.
MIT tests pill to deliver RNA vaccines and therapies
A tortoise-inspired capsule designed by MIT can deliver RNA vaccines and other nucleic acid therapeutics without injections.
Guinea worm disease is near eradication, Carter Center says
After decades of work, cases of human Guinea worm disease are in the double digits — putting elimination of the painful infection in sight.
Can a blood test help diagnose depression?
An objective blood test could help provide a clearer understanding of the patient’s mental health.
Genetically engineered tomato can grow drug to treat Parkinson’s
The latest biopharmaceutical is a drug for Parkinson’s disease, Levodopa, produced by genetically modified tomato plants.
A new superbug strategy
Researchers at the University of Geneva have a new idea on how to stop superbugs: don’t kill them.
Fecal transplants help shrink cancer patients’ tumors
Fecal transplants made advanced melanoma patients who initially didn’t respond to immune checkpoint inhibitors responsive to the cancer treatment.
Frontline healthcare workers are going to receive psilocybin therapy
University of Washington researchers are enrolling healthcare workers now in a psilocybin-assisted therapy study.
Why Einstein is a “peerless genius” and Hawking is an “ordinary genius”
Why some people are considered geniuses while other equally impressive people are not seems largely arbitrary.
Deep brain stimulation can treat OCD without drugs
Stimulating the brain with electricity could be a treatment for OCD. Researchers test electrical stimulation to reduce compulsive behavior.
Series|
Catalysts
8 complete strangers tell their life stories. What happens next is magic
In partnership with Stand Together
One surprising way to boost empathy lies in telling other people’s stories from a first-person perspective.
Deep brain stimulation can be life-altering for OCD sufferers when other treatment options fall short
Deep brain stimulation relies on thin electrodes implanted deep in the brain that deliver electrical currents. Could it treat OCD?
Researchers find a new target for a universal flu vaccine: the “anchor”
There’s a new target in the battle for a universal flu vaccine: the "anchor,” a part of the virus’ proteins less likely to mutate.
The Four Enemies to a happy life and how to defeat them
Buddhist psychologists, Robert Thurman and Sharon Salzberg, have identified "Four Enemies" that are obstacles to a happy, fulfilled life.
Cataract surgery associated with lower risk of dementia
In a new study of thousands of patients, those who had cataract surgery had a reduction in dementia risk.
Mini brains grown in the lab sprout primitive “eyes”
Researchers have grown mini brains with light-sensitive eye structures that could lead to breakthrough treatments for vision disorders.
Oral ketamine treatment reduced suicidal thoughts: Pilot study
A new, small study in Australia suggests that oral ketamine treatment may help treat suicidal thoughts.
Just $50 can turn your phone into a powerful chemical, pathogen detector
If this becomes a common feature of smartphones, it could someday allow anyone to identify pathogens and detect impurities in food.
Four types of Alzheimer’s discovered in international study
A study has identified four distinct types of Alzheimer’s disease, based on how the tau protein spreads in patients’ brains.
The hep C cure may also fight COVID-19
SARS-CoV-2 uses a number of key proteins to infect us, including its main protease. New research has found hepatitis C drugs can bind this protein.
Uber may reduce drunk driving deaths by 6%
Uber is reducing drunk driving deaths by more than 6%, according to a new analysis, suggesting that ridesharing is making streets safer.
Series|
Catalysts
Ex-Google employees are working on America’s prison system
In partnership with Stand Together
The parole system is filling our prisons - with little attention. Now, data engineers, law enforcement and parolees alike are trying to improve the system.
New pancreatic cancer treatment penetrates tough tumors
For a new pancreatic cancer treatment, researchers attached a chemotherapy drug to an antibody that targets a molecule on the outside of cancer cells.
Inhaled CRISPR treatment tackles COVID-19, flu
An inhaled CRISPR treatment can be easily tweaked to attack a variety of viruses, from the one that causes the flu to the coronavirus behind COVID-19.
Series|
Catalysts
Helping Boston’s most notorious gang leaders find a new path
In partnership with Stand Together
This Boston organization, run by ex gang members, has reduced crime by 75%.
First-of-its-kind pilot study uses MDMA for alcohol addiction
A small, first-of-its-kind study has piloted the use of MDMA for alcohol addiction therapy.
DeepMind releases massive protein structure database
DeepMind is releasing a massive database of protein structure predictions that includes all the molecules in the human proteome.
Cooling caps can help prevent chemo hair loss
Chemo hair loss is a common side effect for cancer patients, but cooling caps can help limit the loss.
MDMA couples therapy could help couples dealing with PTSD
A small study out of Canada investigated the potential of using MDMA-assisted couples therapy to treat PTSD.
Yale study: magic mushrooms may grow connections between brain cells
A single dose of psilocybin caused increased growth in neuron-connecting dendritic spines in mice.
Game triggers auditory hallucinations in mice and people
An experimental game that triggers auditory hallucinations in both mice and humans could lead to new treatments for schizophrenia.
Microdosing mushrooms: Explained
Microdosing mushrooms — taking doses of psilocybin too small to cause a trip to enhance daily life — is gaining momentum. But does science support it?
Robots are running COVID-19 drug development
IBM’s new online platform, RoboRXN, combines artificial intelligence, cloud computing, and robotics to automate the COVID-19 drug development process.
Sky-mapping system can predict whether cancer treatment will work
Johns Hopkins researchers are using image analysis developed for astronomy to study cancer immunotherapy.
A major Huntington’s trial has failed. Here’s why there is still hope.
A simple genetic test can determine a person's fate for one of the worst diseases on the planet. But research offers new hope for Huntington's disease.
Therapy can relieve chronic back pain by rewiring the brain
A psychological treatment for chronic back pain left two-thirds of study participants with little-to-no pain after just one month.
This wireless pacemaker dissolves into your body
Researchers at Northwestern and George Washington University have developed a pacemaker that dissolves into the body.
Cancer cells can hibernate to escape chemotherapy
A new study has found evidence that cancer cells hibernate, slowing down their division and waiting out the harsh environment of chemotherapy.
UK researchers are growing the Delta variant for human challenge trials
Responding to the variant’s rise, UK researchers are growing the Delta variant for trials.
First person cured of type 1 diabetes thanks to stem cells
An experimental stem cell treatment has eliminated type 1 diabetes in a patient, giving experts guarded hope for a diabetes cure.
Scientists may have figured out how to fight prion disease
Researchers believe they have found a spot on a mutated prion protein that can lead to brain-spongifying disease.
Experimental procedure zaps nerves to lower blood pressure
Renal denervation, a procedure that uses ultrasound pulses to zap renal nerves, showed promise as a treatment for resistant hypertension in a recent trial.
Editing one gene extends mouse life expectancy by 23%
By modifying just one gene, researchers were able to extend the life expectancy of mice by 23%, and they think their results may translate to humans.
Two opposite kinds of stroke. One promising treatment.
A new stroke treatment could give doctors a way to help victims sooner, improving their chances of avoiding permanent brain damage.
Tuberculosis may spread through aerosols, without coughing
University of Cape Town researchers believe tuberculosis may spread in small aerosols, much like COVID-19.
Scientists can induce out-of-body experiences without drugs
The human brain is a powerful and mysterious place, and researchers have just gotten closer to understanding another important phenomenon taking place inside dissociative experiences.
A blood test for your circadian clock
Your circadian clock controls more than when you sleep and wake. Researchers are developing a simple blood test to try and accurately tell your time.
India’s DNA vaccine for COVID-19 gets emergency approval
India has granted emergency approval to the world's first DNA vaccine for COVID-19.
Weird, synthetic intestinal lining could make treating diseases easier
A synthetic intestinal lining could make it easier for doctors to control drug delivery and nutrient absorption in patients.
How herpes hides
Herpesvirus hides in nerve cells, making it impossible to kill. Now, Northwestern researchers believe they have found the novel key to this nasty trick.
A malaria antibody prevented infections in purposefully-infected volunteers
In a small study, researchers found an antibody that prevents malaria infection in people purposefully infected with the parasite.